US 10407468
Methods for synthesizing α4β7 peptide antagonists
granted A61KA61K38/00A61P
Quick answer
US patent 10407468 (Methods for synthesizing α4β7 peptide antagonists) held by Protagonist Therapeutics, Inc. expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K38/00, A61P, A61P1/00, A61P29/00